Anastasia Kytölä

Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations

A. Palotie, C. Forsblom, P. Groop, 2022, Genome Medicine.

Evidence of a causal effect of genetic tendency to gain muscle mass on uterine leiomyomata

John D. Eicher, M. Obeidat, K. Kristiansson, 2023, Nature Communications.

Novel protein-altering variants associated with serum apolipoprotein and lipid levels

A. Palotie, C. Forsblom, P. Groop, 2021, medRxiv.

Integration of questionnaire-based risk factors improves polygenic risk scores for human coronary heart disease and type 2 diabetes

Beryl B. Cummings, John D. Eicher, Jonathan H. Chung, 2022, Communications Biology.

A FinnGen pilot clinical recall study for Alzheimer’s disease

Pietro Della Briotta Parolo, John D. Eicher, M. Obeidat, 2023, medRxiv.

Whole genome sequencing identifies rare variants in ANK1, LRRN1, HAS1, and other genes and gene regulatory regions for stroke in type 1 diabetes

A. Palotie, P. Groop, N. Sandholm, 2022, medRxiv.

Whole-genome sequencing identifies variants in ANK1, LRRN1, HAS1, and other genes and regulatory regions for stroke in type 1 diabetes

A. Palotie, P. Groop, N. Sandholm, 2024, Scientific reports.